Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Insmed Incorporated - Common Stock (NQ:INSM)

101.89 +3.71 (+3.78%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Insmed Incorporated - Common Stock

< Previous 1 2 3 4 5 6 Next >
Cramer Says Tesla Dominates While Ouster Is 'Too Speculative'
Jim Cramer advises against investing in Tempus AI due to its ongoing losses and suggests Pan American as a profitable alternative. Insmed is also considered speculative while the only viable option for... 
Via Benzinga
Topics Artificial Intelligence
A Glimpse Into The Expert Outlook On Insmed Through 12 Analysts
Via Benzinga
Here's How Much $100 Invested In Insmed 10 Years Ago Would Be Worth Today
Via Benzinga
Russell Rebalance: 3 Stocks Ready to Move Higher
The Russell reconstitution is underway; here are three stocks that are garnering interest as stocks that could move up to the Russell 1000 
Via MarketBeat
What Does the Market Think About Insmed?
Via Benzinga
How Do Investors Really Feel About Insmed?
Via Benzinga
Earnings Scheduled For May 8, 2025
Via Benzinga
Is Insmed Gaining or Losing Market Support?
Via Benzinga
Oracle, AST SpaceMobile And Halliburton Are Among Top 10 Large Cap Gainers Last Week (June 9-13): Are The Others In Your Portfolio?
Top 10 large-cap stocks with biggest gains last week: INSM, CRCL, ORCL, ASTS, SAIL, VG, TEM, CASY, EQNR, HAL. Have you invested in them? 
Via Benzinga
$100 Invested In Insmed 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Insmed's Pulmonary Hypertension Drug Data Exceeded Even Bullish Outlook, Analysts Boost Price Forecast
BofA raises Insmed price target to $109 after strong TPIP data and flags FDA decision on brensocatib as a near-term share catalyst. 
Via Benzinga
Datadog To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
Deep Dive Into Insmed Stock: Analyst Perspectives (6 Ratings)
Via Benzinga
Dow Gains 50 Points; US Small Business Optimism Index Rises In May
Via Benzinga
Topics Stocks
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Which stocks are gapping on Tuesday?
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Tuesday. Let's explore the market movements and identify the stocks with significant gaps. 
Via Chartmill
Insmed, Tesla, Casey's General Stores And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Insmed Stock Soars Pre-market After Lung Disease Drug Achieves Positive Results In Mid-Stage Trial: Retail Gets More Bullish
Insmed said that it will immediately engage with the U.S. Food and Drug Administration (FDA) regarding a late-stage study design following the positive results from the mid-stage trial. 
Via Stocktwits
Topics Death
Insmed Catapults Into Breakout Territory On A 'Home Run' For Its Rival To United, Liquidia
Shares look likely to break out at the open after the biotech company unveiled promising results for a pulmonary arterial hypertension treatment. 
Via Investor's Business Daily
This Insmed Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Via Benzinga
Analyst Expectations For Insmed's Future
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today
Via Benzinga
In The Holiday Shortened Easter Week, These Large-Cap Stock Were Top Performers (Apr 14-Apr 18): Are These In Your Portfolio?
Top performers last week: ServiceTitan, Summit Therapeutics, YPF, Eli Lilly, MicroStrategy, America Movil, Ericsson, Insmed, Diamondback, Neurocrine Biosciences. 
Via Benzinga
Here's How Much You Would Have Made Owning Insmed Stock In The Last 5 Years
Via Benzinga
Friday's after hours session: top gainers and losers
As the regular session of the US market concludes on Friday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses. 
Via Chartmill
A technical analysis of INSMED INC (NASDAQ:INSM).
INSMED INC (NASDAQ:INSM) Reveals Intriguing Technical Aspects. Indications Suggest NASDAQ:INSM Could Be on the Verge of a Breakout. Here's What You Need to Know. 
Via Chartmill
$1000 Invested In Insmed 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Expert Outlook: Insmed Through The Eyes Of 13 Analysts
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.